Telomir Pharmaceuticals TELO Income Statement (2023-2026)

NASDAQ TELO

$1.12 -0.05 (-4.27%)

As of: Aug 20, 2026 · 3:59 PM EDT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Shares Outstanding (Entity) (Quarter)													68.77M
Operating items
Research & Development (Quarter)	0.44M	0.70M	0.59M	0.48M	0.80M	0.59M	0.63M	0.27M	0.34M	0.04M	0.76M	1.30M	0.44M
Selling, General & Administrative (Quarter)	0.04M	0.06M	0.10M	0.40M	0.74M	0.88M	5.38M	2.64M	1.85M	5.03M	0.39M	0.84M	1.32M
Other Operating Expenses (Quarter)		0.67M	0.26M	0.20M	0.37M
Operating Expenses (Quarter)	0.48M	1.43M	0.95M	1.08M	1.92M	1.47M	6.01M	2.91M	2.19M	5.07M	1.15M	2.13M	1.76M
Non-operating items
Interest & Investment Income (Quarter)						0.03M	0.02M	0.01M		0.00M	0.04M	0.07M	0.05M
Other Non Operating Income (Quarter)										20.00			0.04M
Non Operating Income (Quarter)			-0.76M		-4.34M		0.02M		0.01M		0.04M
Net income details
Profit After Tax (Quarter)													-1.72M
Preferred Dividend Payments (Quarter)													46.11M
Net Income towards Common Stockholders (Quarter)										-5.07M			-47.84M
Additional items
Shares Outstanding (Quarter)													60.84M
Shares Outstanding (Diluted) (Quarter)													60.84M
EPS (Basic) (Quarter)										-0.17			-0.79
Interest Expenses (Quarter)													0.00M
EPS (Diluted) (Quarter)										-0.17			-0.79